Heidelberg Pharma AG (ETR:HPHA)

PRESS RELEASE

published on 01/13/2025 at 08:17, 1 year 7 months ago

Heidelberg Pharma Progresses into Cohort 7 in a Phase I/IIa Study with BCMA ATAC Candidate HDP-101 Targeting Multiple Myeloma
Heidelberg Pharma advances into Cohort 7 with BCMA ATAC candidate HDP-101 targeting multiple myeloma, showing promising results and complete remission in Phase I/IIa study

Heidelberg Pharma Multiple Myeloma Phase I/IIa Study Complete Remission BCMA ATAC
BRIEF

published on 11/06/2024 at 10:07, 1 year 9 months ago

Heidelberg Pharma Reveals Promising Data on HDP-101 at ASH 2024

Clinical Data Heidelberg Pharma HDP-101 ADC Technology Multiple Myeloma
BRIEF

published on 11/06/2024 at 10:07, 1 year 9 months ago

Heidelberg Pharma dévoile des données prometteuses sur le HDP-101 à l'ASH 2024

Heidelberg Pharma HDP-101 Myélome Multiple Données Cliniques Technologie ADC
PRESS RELEASE

published on 11/06/2024 at 10:02, 1 year 9 months ago

Heidelberg Pharma: Promising New Clinical Data on Lead ADC-Candidate HDP-101 to be Presented at ASH Annual Meeting 2024
Heidelberg Pharma AG to present promising new clinical data on lead ADC-candidate HDP-101 at ASH Annual Meeting 2024, showcasing potential for multiple myeloma treatment

Clinical Data HDP-101 Heidelberg Pharma AG ADC ASH Annual Meeting
BRIEF

published on 10/24/2024 at 11:08, 1 year 10 months ago

Heidelberg Pharma to Showcase Its ADC Innovations in November 2024

Cancer Therapy Heidelberg Pharma HDP-101 ADCs HDP-201
BRIEF

published on 10/24/2024 at 11:08, 1 year 10 months ago

Heidelberg Pharma présentera ses innovations ADC en novembre 2024

Heidelberg Pharma HDP-101 Thérapie Contre Le Cancer ADC HDP-201
PRESS RELEASE

published on 10/24/2024 at 11:03, 1 year 10 months ago

Heidelberg Pharma to Participate in Leading Scientific and Financial Conferences in November 2024
Heidelberg Pharma to present ADC candidates at scientific and financial conferences in November 2024. Updates on Amanitin-based HDP-101 and Exatecan-based HDP-201. Key targets and conference details

Heidelberg Pharma Scientific Conferences ADC Candidates Amanitin Exatecan
BRIEF

published on 10/10/2024 at 07:11, 1 year 10 months ago

Heidelberg Pharma AG's Interim Report for First Nine Months of 2024

Financial Report Heidelberg Pharma HDP-101 Trial Clinical Outcomes Royalty Sale
BRIEF

published on 10/10/2024 at 07:11, 1 year 10 months ago

Rapport intermédiaire de Heidelberg Pharma AG pour les neuf premiers mois de 2024

Rapport Financier Heidelberg Pharma Résultats Cliniques Essai Du HDP-101 Vente De Redevances
PRESS RELEASE

published on 10/10/2024 at 07:06, 1 year 10 months ago

Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2024
Heidelberg Pharma AG provides insights on its operational progress and financial figures for the first nine months of fiscal year 2024. Development activities, new clinical data, R&D webinars, and guidance updates are highlighted

Financial Figures Clinical Data Heidelberg Pharma AG R&D Webinars Guidance Updates

Published on 08/28/2026 at 14:00, 8 hours 41 minutes ago

Lobe Sciences Expands Leadership Team with New CFO Appointment
Published on 08/28/2026 at 13:00, 9 hours 41 minutes ago

Abasca Files NI 43-101 Technical Report, Commences Summer Exploration Program at Loki and Elects to File Semi-annual Interim Financial Statements and Related MD&A
Published on 08/28/2026 at 08:05, 14 hours 36 minutes ago

Caledonia Mining Corporation Plc: Maiden Mineral Resource Estimate at Motapa 379,000 oz Measured and Indicated; 131,000 oz Inferred
Published on 08/28/2026 at 08:05, 14 hours 36 minutes ago

Tocvan Announces New Surface Mineralization in Several Zones at Gran Pilar Gold-Silver Project
Published on 08/28/2026 at 08:00, 14 hours 41 minutes ago

Caledonia Mining Corporation Plc: Blanket Mine Underground Measured and Indicated Mineral Resources Estimate Increases by 22% to 2.18 Million Ounces and Declaration of a Surface Mineral Resource Estimate

View all ACCESSWIRE

Published on 08/28/2026 at 20:49, 1 hour 51 minutes ago

Publication pursuant to Article 5(1)(b) and (3) of Regulation (EU) No. 596/2014 and Article 2(2) and (3) of the Commission Delegated Regulation (EU) No. 2016/1052 - Final Announcement
Published on 08/28/2026 at 20:42, 1 hour 59 minutes ago

Aroundtown SA: Release of a capital market information
Published on 08/28/2026 at 19:10, 3 hours 30 minutes ago

Invitation to Professional or Qualified Investors holding Notes to submit offers for Branicks Bridge Notes and VIB Bridge Notes
Published on 08/28/2026 at 18:01, 4 hours 39 minutes ago

CPI Europe announces unaudited results for the first half of 2026
Published on 08/28/2026 at 18:00, 4 hours 41 minutes ago

Highlight Event and Entertainment AG publishes results for the first half of 2026

View all EQS

Published on 08/28/2026 at 18:27, 4 hours 14 minutes ago

Droits de vote au 31-07-2026
Published on 08/28/2026 at 18:25, 4 hours 16 minutes ago

Droits de vote au 30-06-2026
Published on 08/28/2026 at 17:45, 4 hours 56 minutes ago

STEF : Droits de vote au 31 07 2026
Published on 08/28/2026 at 06:55, 15 hours 46 minutes ago

Recticel Accelerates Profitable Growth
Published on 08/28/2026 at 06:55, 15 hours 46 minutes ago

Recticel versnelt winstgevende groei

View all LES ECHOS COMFI WIRE

News